Literature DB >> 10488150

In vitro assembly of human immunodeficiency virus type 1 Gag protein.

Y Morikawa1, T Goto, K Sano.   

Abstract

Retroviral Gag protein is sufficient to produce Gag virus-like particles when expressed in higher eukaryotic cells. Here we describe the in vitro assembly reaction of human immunodeficiency virus Gag protein, which consists of two sequential steps showing the optimal conditions for each reaction. Following expression and purification, Gag protein lacking only the C-terminal p6 domain was present as a monomer (50 kDa) by velocity sedimentation analysis. Initial assembly of the Gag protein to 60 S intermediates occurred by dialysis at 4 degrees C in low salt at neutral to alkaline pH. However, higher order of assembly required incubation at 37 degrees C and was facilitated by the addition of Mg(2+). Prolonged incubation under these conditions produced complete assembly (600 S), equivalent to Gag virus-like particles obtained from Gag-expressing cells. Neither form disassembled by treatment with nonionic detergent, suggesting that correct assembly might occur in vitro. Electron microscopic observation confirmed that the 600 S assembly products were spherical particles similar to authentic immature human immunodeficiency virus particles. The latter assembly stage but not the former was accelerated by the addition of RNA although not inhibited by RNaseA treatment. These results suggest that Gag protein alone assembles in vitro, but that additional RNA facilitates the assembly reaction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10488150     DOI: 10.1074/jbc.274.39.27997

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Nucleic acid-independent retrovirus assembly can be driven by dimerization.

Authors:  Marc C Johnson; Heather M Scobie; Yu May Ma; Volker M Vogt
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  The late stage of human immunodeficiency virus type 1 assembly is an energy-dependent process.

Authors:  M Tritel; M D Resh
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Molecular factors required for human immunodeficiency virus type I infectivity.

Authors:  A G Bukrinskaya; G K Vorkunova; M E Burshteĭn; T V Gorodnicheva; M Stevenson
Journal:  Dokl Biol Sci       Date:  2005 Jul-Aug

4.  Gag-Pol supplied in trans is efficiently packaged and supports viral function in human immunodeficiency virus type 1.

Authors:  M K Hill; C W Hooker; D Harrich; S M Crowe; J Mak
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Domain-swapped dimerization of the HIV-1 capsid C-terminal domain.

Authors:  Dmitri Ivanov; Oleg V Tsodikov; Jeremy Kasanov; Tom Ellenberger; Gerhard Wagner; Tucker Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

6.  Distinct roles for nucleic acid in in vitro assembly of purified Mason-Pfizer monkey virus CANC proteins.

Authors:  Pavel Ulbrich; Sarka Haubova; Milan V Nermut; Eric Hunter; Michaela Rumlova; Tomas Ruml
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

7.  Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin.

Authors:  Sheli R Radoshitzky; Lian Dong; Xiaoli Chi; Jeremiah C Clester; Cary Retterer; Kevin Spurgers; Jens H Kuhn; Sarah Sandwick; Gordon Ruthel; Krishna Kota; Dutch Boltz; Travis Warren; Philip J Kranzusch; Sean P J Whelan; Sina Bavari
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

8.  Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication.

Authors:  Sook-Kyung Lee; Kunio Nagashima; Wei-Shau Hu
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

9.  Characterization of Rous sarcoma virus Gag particles assembled in vitro.

Authors:  F Yu; S M Joshi; Y M Ma; R L Kingston; M N Simon; V M Vogt
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

10.  Nucleic acid binding-induced Gag dimerization in the assembly of Rous sarcoma virus particles in vitro.

Authors:  Yu May Ma; Volker M Vogt
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.